Parkinson's Disease clinical trials in North Carolina
20 active Parkinson's Disease trials with a site in North Carolina. Describe your situation to see which ones look like a fit.
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- A Study of Buntanetap in Participants With PD
- Use of CereGate Therapy for Freezing of Gait in PD
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Parkinson's Foundation PD GENEration Genetic Registry
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
- Registry of Deep Brain Stimulation With the VERCISEā¢ System: Vercise DBS Registry
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Retinal Imaging in Neurodegenerative Disease
- Apathy in Parkinson Disease TMS Study
- Closed Loop DBS Implanted RC+S Study
- Connectomic Guided DBS for Parkinson's Disease
- Effects of Stimulation Patterns of Deep Brain Stimulation
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.